As long-haul infections continue to surge, and climate change pushes ticks into new habitats, finding out the causes of these conditions and coming up with cures will become ever more essential.
Related Posts
As Novo Nordisk scales back, Eris and Biocon Biologics hit the sweet spot in India’s insulin market
“It is a small emergency,” says Amit Bakshi, chairman of Ahmedabad-based drugmaker Eris Lifesciences. He points to the recent decision…
syngene: Syngene gets booster dose of sky-high valuation, but investors cautiously upbeat on stock
Contract research and manufacturing company Syngene International has had a fabulous run this year. Its stock price has risen over…
Sun Pharma’s earnings pace is likely to slow down as it takes two steps back for a leap forward
A bird flies past the logo of Sun Pharma installed on the facade of its corporate office in Mumbai, India.…
